Latest Nuvelo Stories

2014-04-28 08:31:55

REDWOOD CITY, Calif., April 28, 2014 /PRNewswire/ -- Coherus Biosciences, Inc. ("Coherus"), is pleased to announce the appointment of Michael A. Fleming as Senior Vice President, Commercial Strategy. Mr. Fleming joins Coherus with more than 25 years of experience in strategic and operational leadership roles at preeminent biotech companies. "Michael is a vital addition to the Coherus team at this time," said Denny Lanfear, President and CEO of Coherus. "Our pipeline is now...

2014-01-30 16:26:49

DUBLIN, January 30, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/sxtcgx/cancer_diagnostic) has announced the addition of the "Cancer Diagnostic Testing World Markets" [http://www.researchandmarkets.com/research/sxtcgx/cancer_diagnostic ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Cancer testing is one of the most important growth opportunities for the next three to five years in...

2010-12-21 08:00:00

ALBUQUERQUE, N.M., Dec. 21, 2010 /PRNewswire/ -- Exagen Diagnostics, Inc., a specialty diagnostics laboratory that discovers, develops and markets proprietary tests, today announced that it has been awarded $400,000 in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program, which was created by Congress as part of the Patient Protection and Affordable Care Act of 2010. Proceeds from the grants will be used to advance the development of biomarker studies underway,...

2010-09-22 10:15:00

NEW YORK, Sept. 22 /PRNewswire/ -- Signal Genetics, a privately held predictive genetic testing company focused on oncology, today announced the company will work with Array BioPharma to help push forward both companies' goals of markers for patient selection, helping bring personalized medicine and companion diagnostics to patients with multiple myeloma, a cancer of the bone marrow and antibody producing cells. Signal Genetics' groundbreaking MyPRS(TM) genomic testing platform will be...

2010-03-17 06:30:00

SAN DIEGO, March 17 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially...

Word of the Day
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.